K-m Kim - Publications

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 11, 2020

Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 10, 2019

PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer.

Journal: Oncoimmunology

Published: July 25, 2018

Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.

Journal: The British journal of surgery

Published: January 06, 2018

Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 29, 2016

Novel strategy for a bispecific antibody: induction of dual target internalization and degradation.

Journal: Oncogene

Published: October 01, 2015

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 12, 2015

Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer.

Journal: The British journal of surgery

Published: November 12, 2014

Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 31, 2014

The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 01, 2014

Innovative personalized medicine in gastric cancer: time to move forward.

Journal: Clinical genetics

Published: January 15, 2014

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours.

Journal: British journal of cancer

Published: March 28, 2013